Koyfin Home > Directory > Health Care > Aquestive Therapeutics Inc > EBITDA

Aquestive Therapeutics Inc EBITDA Chart (AQST)

Aquestive Therapeutics Inc annual/quarterly EBITDA from 2006 to 2018. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Aquestive Therapeutics Inc EBITDA for the quarter ending December 12, 2018 was $-12m a 154.38% decrease of -18m year over year
  • Aquestive Therapeutics Inc EBITDA for the last 12 months ending December 12, 2018 was $-21m a 140.35% decrease of -29m year over year
  • Aquestive Therapeutics Inc Annual EBITDA for 2018 was $-21m a 118.38% decrease of -25m from 2017
  • Aquestive Therapeutics Inc Annual EBITDA for 2017 was $4m a 17.30% increase of 1m from 2016
  • Aquestive Therapeutics Inc Annual EBITDA for 2016 was $3m a 424.63% increase of 13m from 2015
Other Income Statement Metrics:
  • Aquestive Therapeutics Inc Net Income for the quarter ending December 12, 2018 was $-14m a 129.40% decrease of -18m year over year
  • Aquestive Therapeutics Inc Total Revenue for the quarter ending December 12, 2018 was $17m a -39.15% decrease of -7m year over year
View Chart On Koyfin

Quarterly AQST EBITDA Data

12/2018$-12m
09/2018$-8m
06/2018$-32m
03/2018$6m
12/2017$-6m
09/2017$11m
06/2017$-3m
03/2017$2m
06/2007$-3m
03/2007$-3m

Annual AQST EBITDA Data

2018$-21m
2017$4m
2016$3m
2006$-10m
2005$-7m
2004$-3m